URETHRAL CANCER

URETHRAL CANCER was reported 216 times

URETHRAL CANCER is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 2 0.0029
1 Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] 2 0.0011
2 Blood Viscosity Reducer [EPC] 1 0.0002
3 Provitamin D2 Compound [EPC] 4 0.0001
4 Parenteral Iron Replacement [EPC] 1 0.0001
5 Peroxisome Proliferator Receptor alpha Agonist [EPC] 4 0.0001
6 Nonergot Dopamine Agonist [EPC] 1 0.0001
7 Interleukin-17A Antagonist [EPC] 2 0.0001
8 CD52-directed Cytolytic Antibody [EPC] 1 0.0001
9 Pyridone [EPC] 2 0.0000
10 Human Immunoglobulin G [EPC] 1 0.0000
11 PCSK9 Inhibitor [EPC] 1 0.0000
12 Prostacyclin Receptor Agonist [EPC] 1 0.0000
13 Integrin Receptor Antagonist [EPC] 3 0.0000
14 Iron Chelator [EPC] 1 0.0000
15 Oxazolidinone Antibacterial [EPC] 1 0.0000
16 Sulfonylurea [EPC] 4 0.0000
17 Sympathomimetic-like Agent [EPC] 1 0.0000
18 Dipeptidyl Peptidase 4 Inhibitor [EPC] 1 0.0000
19 Soluble Guanylate Cyclase Stimulator [EPC] 1 0.0000
20 Androgen Receptor Inhibitor [EPC] 2 0.0000
21 Muscle Relaxant [EPC] 1 0.0000
22 Ester Local Anesthetic [EPC] 1 0.0000
23 Vitamin D [EPC] 6 0.0000
24 Thiazide Diuretic [EPC] 4 0.0000
25 Vitamin C [EPC] 8 0.0000
26 Interleukin-23 Antagonist [EPC] 2 0.0000
27 Macrolide Antimicrobial [EPC] 1 0.0000
28 HMG-CoA Reductase Inhibitor [EPC] 7 0.0000
29 Erythropoiesis-stimulating Agent [EPC] 1 0.0000
30 Vitamin B12 [EPC] 6 0.0000
31 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 2 0.0000
32 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2 0.0000
33 Complement Inhibitor [EPC] 1 0.0000
34 Methylxanthine [EPC] 1 0.0000
35 Insulin Analog [EPC] 7 0.0000
36 Thalidomide Analog [EPC] 8 0.0000
37 Dihydropyridine Calcium Channel Blocker [EPC] 5 0.0000
38 Selective T Cell Costimulation Modulator [EPC] 2 0.0000
39 Cardiac Glycoside [EPC] 1 0.0000
40 Non-Standardized Chemical Allergen [EPC] 1 0.0000
41 Janus Kinase Inhibitor [EPC] 2 0.0000
42 Platelet Aggregation Inhibitor [EPC] 7 0.0000
43 Catecholamine [EPC] 1 0.0000
44 Microtubule Inhibitor [EPC] 2 0.0000
45 Corticosteroid [EPC] 15 0.0000
46 Xanthine Oxidase Inhibitor [EPC] 2 0.0000
47 Amide Local Anesthetic [EPC] 1 0.0000
48 Nitrate Vasodilator [EPC] 1 0.0000
49 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1 0.0000
50 Platinum-based Drug [EPC] 3 0.0000
51 Factor Xa Inhibitor [EPC] 3 0.0000
52 Dietary Cholesterol Absorption Inhibitor [EPC] 1 0.0000
53 Estrogen [EPC] 2 0.0000
54 Partial Opioid Agonist [EPC] 1 0.0000
55 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
56 Antiarrhythmic [EPC] 1 0.0000
57 Aminosalicylate [EPC] 1 0.0000
58 RANK Ligand Inhibitor [EPC] 2 0.0000
59 beta-Adrenergic Blocker [EPC] 3 0.0000
60 Angiotensin 2 Receptor Blocker [EPC] 3 0.0000
61 Atypical Antipsychotic [EPC] 4 0.0000
62 Loop Diuretic [EPC] 4 0.0000
63 Proteasome Inhibitor [EPC] 1 0.0000
64 P2Y12 Platelet Inhibitor [EPC] 1 0.0000
65 Alkylating Drug [EPC] 2 0.0000
66 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
67 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
68 Opioid Agonist [EPC] 2 0.0000
69 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
70 Kinase Inhibitor [EPC] 4 0.0000
71 Tumor Necrosis Factor Blocker [EPC] 7 0.0000
72 Nonsteroidal Anti-inflammatory Drug [EPC] 9 0.0000
73 Proton Pump Inhibitor [EPC] 4 0.0000
74 Calcium [EPC] 1 0.0000
75 Aldosterone Antagonist [EPC] 1 0.0000
76 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
77 Expectorant [EPC] 1 0.0000
78 Folate Analog Metabolic Inhibitor [EPC] 2 0.0000
79 Benzodiazepine [EPC] 3 0.0000
80 Retinoid [EPC] 1 0.0000
81 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
82 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
83 GLP-1 Receptor Agonist [EPC] 1 0.0000
84 Interleukin-4 Receptor alpha Antagonist [EPC] 1 0.0000